Current Opinion in Molecular Therapeutics

Published by: Thomson Reuters  

Groups

  1. Center for Hematologic Malignancies (2)
  2. Adult Leukemia (1)
  3. Epidemiology and Biostatistics (1)
  4. Health Outcomes Research Group (1)
  5. Hematologic Malignancies Research (1)
  6. Hematologic Malignancies Research (1)
  7. Hematologic Oncology, Division of (1)
  8. Leukemia Service (1)
  9. Molecular Pharmacology and Chemistry Program Faculty (1)
  10. Population Sciences Research Program (1)

Current Opinion in Molecular Therapeutics – authorized name for:

Name ISSN / ISBN Publisher
Current Opinion in Molecular Therapeutics 1464-8431 Thomson Reuters
Current Opinion in Molecular Therapeutics 1464-8431 Thomson Reuters
Current Opinion in Molecular Therapeutics 14648431 Thompson Current Drugs
Current Opinion in Molecular Therapeutics 1464-8431 Pharmapress Ltd
Current Opinion in Molecular Therapeutics 14648431 The Thomson Corporation
Current Opinion in Molecular Therapeutics 1464-8431 Current Drugs Ltd
Current Opinion in Molecular Therapeutics 14648431 Unknown